Vela Acquisition Corporation
Records under this name other than patents Vela Acquisition Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 5 of 5 · Back to Vela Acquisition Corporation
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,649,607 | Compositions and methods for treating or preventing convulsions or seizures Term ended Term ended Nov 9, 2021 · USPTO record | Term ended | Term ended Nov 9, 2021 | USPTO record |
| US 7,541,355 | Conversion process for 2,3-benzodiazepine enantiomers Lapsed on the fee record Ended Jun 2, 2021 · USPTO record | Lapsed on the fee record | Ended Jun 2, 2021 | USPTO record |
| US 6,080,736 | Methods and compositions for treating and preventing anxiety and anxiety disorders using optically pure (R) tofisopam Term ended Term ended Oct 27, 2019 · USPTO record | Term ended | Term ended Oct 27, 2019 | USPTO record |
| US 7,265,106 | Method for isolating (R)-tofisopam Lapsed on the fee record Ended Sep 4, 2015 · USPTO record | Lapsed on the fee record | Ended Sep 4, 2015 | USPTO record |
| US 7,745,431 | Pharmaceutical composition of 1-(3,4-dimethoxyphenyl)-4-methyl-5-ethyl-7-methoxy-8-hydroxy-5H-2,3-benzodiazepine and uses thereof Lapsed on the fee record Ended Jun 29, 2014 · USPTO record | Lapsed on the fee record | Ended Jun 29, 2014 | USPTO record |